AI assistant
Sending…
TScan Therapeutics, Inc. — Director's Dealing 2021
Sep 9, 2021
34191_dirs_2021-09-09_3841ecbd-c911-415f-9e4a-612a11a01486.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: TScan Therapeutics, Inc. (TCRX)
CIK: 0001783328
Period of Report: 2021-09-07
Reporting Person: ZDRAVESKI ZORAN (Chief Legal Officer)
More from TScan Therapeutics, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
May 22
Interim / Quarterly Report
2026
May 6
Earnings Release
2026
May 6
Annual Report
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Board/Management Information
2026
Apr 2
Annual Report
2026
Mar 4
Earnings Release
2026
Mar 4
Director's Dealing
2026
Jan 22
Director's Dealing
2026
Jan 22